28-07-2022 12:00 via wallstreet-online.de

RepliCel’s Manufacturing Inspected by Japan’s PMDA

After over a year of pandemic-related delays, representatives of Japan's PMDA, attended at the Company's contract manufacturing facility, Innovacell, to review the manufacturing of RepliCel's NBDS cell therapy productsVANCOUVER, BC / ACCESSWIRE / …
Weiterlesen »